Cheng VCC, Wong SC, Chen JHK, Yip CCY, Chuang VWM, Tsang OTY, et al. Escalating an infection control response to the quickly evolving epidemiology of the coronavirus illness 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Mizumoto K, Chowell G. Estimating risk for dying from 2019 novel coronavirus illness, China, January–February 2020. A examine analyzing antibody manufacturing in coronavirus illness 2019 (COVID-19) patients and the potential role of serology in prognosis. Preliminary estimates of the prevalence of chosen underlying medical conditions among patients with coronavirus disease 2019 — United States, February 12–March 28, 2020. This research describes presymptomatic coronavirus disease 2019 (COVID-19) infections and transmission in a talented nursing facility in King County, Washington. The authors describe the detection of SARS-CoV-2 in semen specimens from a cohort of patients with confirmed coronavirus disease 2019 (COVID-19) in a hospital in Shangqiu, China.
Genomic variety of SARS-CoV-2 in coronavirus illness 2019 sufferers. Severe outcomes amongst patients with coronavirus disease 2019 (COVID-19) — United States, February 12–March 16, 2020. Epidemiological traits of 2143 pediatric sufferers with 2019 coronavirus illness in China. Antibody responses to SARS-CoV-2 in patients of novel coronavirus illness 2019.